FDA approves Novo's diabetes drug; Walgreens undergoes rebranding in the wake of CVS-Aetna merger; pharma increasingly transparent about clinical trial data
In April, a month or so after brands were accused of funding terrorist videos on YouTube, Procter & Gamble cut down the number of sites its ads ran on by 69%.
Porter Novelli has been appointed to lead a new global CSR brief for pharma and consumer goods giant Johnson & Johnson, as the company faces a major reputation challenge in the US.
The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.
The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.
Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.
She is director of OTC brand marketing at Dr. Reddy's Laboratories.
Celgene's Revlimid tops the list, according to data compiled by EvaluatePharma.
Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.
The drugmaker saw a gap in patient-physician conversation about retinal disease.
As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.
The presumption is Dr. A saw ad B, clicked on it, went to the site and within C time, prescribed product D.
"Find exactly what your audience wants, find exactly where they spend their time, and deliver."
The connection to Pristiq is not overt in the app's user interface, though Moodivator is featured on Pristiq's website.
Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.
Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.
In the United States, people over 50 are often stereotyped as complacent, set in their ways and extremely loyal to their preferred brands, but a new study released Tuesday by Ketchum found that the opposite is true.
CDM New York populated this engaging and outstanding website for Salix with unique visuals and messaging elements designed to drive awareness.
In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.
Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan's executive pay is now under scrutiny
In 2011 the drugmaker spent $9.4 million on branded ads for the EpiPen. By 2015, branded ad spending hit $43 million.
Will this payer pressure pose an existential threat to co-pay cards even though patients love them?
PhRMA brings on new members, Amgen partners with Daiichi Sankyo on biosimilar commercialization in Japan; Thomson Reuters to sell science unit
Executives attending Cannes Lions Health weigh in on the imbalance seen in the U.S. between branded and unbranded drug ads.
A rundown of MM&M at Cannes, and five burning questions heading into the Lions Health festival and awards.
If you truly understand who your high writers and compliant patients are, you'll understand when and how to communicate with prospects that look and act like them.
Pharma marketers are wondering if these exorbitant media buys ($4.9 million for 30 seconds) were worth the investment for Valeant and AstraZeneca. Was either strategy successful?
IPG's McCann Health announces branding and operational changes aimed at integrating its US and Canadian shops.
Dr. Reddy's is blocked from selling generic purple Nexium; the FDA approves Roche's melanoma drug; Novartis says Entresto keeps heart-failure patients from being readmitted to the hospital
We're not out to reinvent the wheel if we don't have to but we will need to localize the campaign for New Zealand and do what is right for our physicians and our patients.